Passive Bonds

iShares iBonds Dec 2026 Term Corporate ETF

The iShares iBonds Dec 2026 Term Corporate ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2026.

$24.22

Key Metrics

TER 10.00% per year
Distribution policy Distributing
Fund size USD 3,799 M
Inception date September 13, 2016
Holdings 546
Fund currency USD
Fund domicile US
Provider iShares
For full official fund details, factsheets, and holdings, visit ishares.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
iBonds Dec 2026 Term Corporate ETF IBDR
Fund Size
$4.2B
Dividend
4.1%
Fees
10.00%
Total Stock Market Index Fund VTSAX
Fund Size
$1.99T
Dividend
1.0%
Fees
4.00%
Total Stock Market Index Fund VTI
Fund Size
$1.99T
Dividend
1.0%
Fees
3.00%
500 Index Fund VFINX
Fund Size
$1.42T
Dividend
0.9%
Fees
-
500 Index Fund VFIAX
Fund Size
$1.42T
Dividend
1.0%
Fees
4.00%
View 1334 similar ETFs →

Historical Return

Last updated: Jun 15, 2026
1 Year +0.2% +4.1% Div
3 Years (avg.) +1.0% +4.1% Div
5 Years (avg.) -1.9% +4.1% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

1.18% 1 Year
1.99% 3 Years
3.41% 5 Years
4.91% 10 Years

Max Drawdown

-0.58% 1 Year
-1.91% 3 Years
-15.25% 5 Years
-16.31% 10 Years

Sharpe Ratio

-3.49 1 Year
-1.68 3 Years
-1.79 5 Years
-0.91 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2016 -4.2% -1.0% -2.7% 0.4% 1.6% 0.7% -0.9% -0.6% -0.4% -0.3%
2017 2.2% -1.9% 2.0% 3.1% 1.7% -0.4% 0.0% 0.1% 0.2%
2018 -5.8% 2.0% 3.4% 1.6% -0.9% -0.4% -0.2% -0.1%
2019 10.4% 8.3% 4.1% 0.4% 0.7% 0.8% 0.8%
2020 6.2% 1.2% -2.8% -1.5% -1.0% -0.8%
2021 -3.7% -7.0% -4.0% -2.8% -2.1%
2022 -10.1% -4.2% -2.5% -1.7%
2023 2.2% 1.6% 1.3%
2024 1.0% 0.8%
2025 0.7%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%
4%
1y 3y N/A N/A
0 - 5%
14%
1y 3y N/A N/A
5 - 10%
16%
1y 3y N/A N/A
10 - 15%
14%
1y 3y N/A N/A
15 - 20%
23%
1y 3y N/A N/A
20 - 30%
21%
1y 3y N/A N/A
30 - 40%
7%
1y 3y N/A N/A
> 40%
2%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
4%
1y 3y N/A N/A
0 - 10
8%
1y 3y N/A N/A
10 - 15
12%
1y 3y N/A N/A
15 - 20
27%
1y 3y N/A N/A
20 - 25
15%
1y 3y N/A N/A
25 - 35
19%
1y 3y N/A N/A
35 - 50
8%
1y 3y N/A N/A
> 50
8%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.1%
1y 3y N/A N/A
Small Cap
1.1%
1y 3y N/A N/A
Mid Cap
5.1%
1y 3y N/A N/A
Large Cap
55.1%
1y 3y N/A N/A
Mega Cap
38.6%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Jun 15, 2026
6.0% Top 5 Holdings
10.8% Top 10 Holdings
36.6% Top 50 Holdings
55.0% Top 100 Holdings
Top 5 Companies
BA Boeing Co.
1.5%
MSFT Microsoft Corporation
1.3%
ABBV Abbvie Inc
1.3%
T AT&T, Inc.
1.0%
ORCL Oracle Corp.
1.0%

Latest News

about 9 hours ago • prnewswire.com

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

SKYRIZI ® (risankizumab) expands its indication for children and adolescents six years of age and older with moderate to severe plaque psoriasis 1 ...

about 13 hours ago • fool.com

Why AbbVie Stock Jumped Today

AbbVie is making smart moves to bolster its lucrative immunology business. The healthcare leader is working to diversify its sales and profits.

about 17 hours ago • fool.com

AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?

The deal gives the company a strong asset in zumilokibart, Apogee's very promising investigational drug. Apogee stockholders are to be paid $135.11...

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $438B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.09% 2.03%
Beta Indicates the relationship between the price performance of a share and the market. 0.86 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 27.79 28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -56.34 -
Profitable Companies 95% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 34.44 14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 3.78 8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 6.08 10.72
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 20.36 21.15
Enterprise Value to Revenue Enterprise value divided by revenue 5.23 8.72
Total Debt to Enterprise Value Total debt divided by enterprise value 0.36 0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.77 0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 15.30% -6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +28.0% -117.9%
Return on Equity Equity divided by market cap. 19.64% 1.23%
Return on Assets Indicates a company's profitability in relation to its total assets. 6.39% 3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 11.29% 3.31%

Sectors

Finance and Insurance 18.1%
Manufacturing 17.7%
Information 6.0%
Retail Trade 4.5%
Financial Services 3.1%
Utilities 3.1%
Transportation and Warehousing 2.3%
Professional, Scientific, and Technical Services 1.8%
Finance 1.6%
Real Estate and Rental and Leasing 0.7%
Management of Companies and Enterprises 0.6%
Administrative and Support and Waste Management and Remediation Services 0.4%
Wholesale Trade 0.4%
Health Technology 0.2%
Construction 0.2%
Arts, Entertainment, and Recreation 0.2%
Mining, Quarrying, and Oil and Gas Extraction 0.1%
Health Care and Social Assistance 0.1%
Other 38.8%

Countries

United States 79.8%
Canada 8.0%
Japan 3.7%
Other 3.6%
Ireland 1.9%
Australia 1.0%
Netherlands 0.9%
United Kingdom 0.6%
Chile 0.2%
France 0.2%
Other 0.0%

Stock Screener

Select filters to narrow down the 237 investments below

237 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $175.57B
P/E Ratio 92.0
Dividends 0.0%
Total Investment $34.33M
Weight 0.90%

Loading details…

Market Cap $2.82T
P/E Ratio 22.5
Dividends 0.9%
Total Investment $29.96M
Weight 0.79%

Loading details…

Market Cap $382.74B
P/E Ratio 106.2
Dividends 3.1%
Total Investment $29.87M
Weight 0.79%

Loading details…

Market Cap $179.83B
P/E Ratio 7.2
Dividends 5.0%
Total Investment $23.65M
Weight 0.62%

Loading details…

Market Cap $530.08B
P/E Ratio 31.0
Dividends 1.1%
Total Investment $23.26M
Weight 0.61%

Loading details…

Market Cap $871.43B
P/E Ratio 15.4
Dividends 1.8%
Total Investment $23.21M
Weight 0.61%

Loading details…

Market Cap $352B
P/E Ratio 19.3
Dividends 1.8%
Total Investment $23.09M
Weight 0.61%

Loading details…

Loading details…

Market Cap $244.05B
P/E Ratio 17.5
Dividends 1.7%
Total Investment $22.59M
Weight 0.59%

Loading details…

Market Cap $4.38T
P/E Ratio 35.9
Dividends 0.4%
Total Investment $22.14M
Weight 0.58%

Loading details…

Market Cap $153.66B
P/E Ratio 16.7
Dividends 2.6%
Total Investment $21.37M
Weight 0.56%

Loading details…

Market Cap $2.63T
P/E Ratio 28.8
Dividends 0.0%
Total Investment $21.2M
Weight 0.56%

Loading details…

Market Cap $530.08B
P/E Ratio 31.0
Dividends 1.1%
Total Investment $20.97M
Weight 0.55%

Loading details…

Market Cap $323.49B
P/E Ratio 19.8
Dividends 1.6%
Total Investment $20.55M
Weight 0.54%

Loading details…

Market Cap $571.22B
P/E Ratio 22.8
Dividends 3.0%
Total Investment $19.94M
Weight 0.52%

Loading details…

Loading details…

Market Cap $398.83B
P/E Ratio 13.7
Dividends 2.0%
Total Investment $19.24M
Weight 0.51%

Loading details…

Market Cap $871.43B
P/E Ratio 15.4
Dividends 1.8%
Total Investment $19.08M
Weight 0.50%

Loading details…

Market Cap $4.38T
P/E Ratio 35.9
Dividends 0.4%
Total Investment $17.51M
Weight 0.46%

Loading details…

Loading details…